Standard BioTools Inc. (LAB)

Standard BioTools Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	210.65	51.7	81.31	28.45	68.52	21.66
Short-Term Investments	155.68	63.19	84.48	-	-	36.98
Cash & Short-Term Investments	366.33	114.9	165.78	28.45	68.52	58.64
Cash Growth	184.31%	-30.70%	482.70%	-58.48%	16.85%	-38.53%
Receivables	35.32	19.66	17.28	18.32	25.42	18.98
Inventory	42.64	20.53	21.47	20.83	19.69	13.88
Prepaid Expenses	9.32	3.13	4.28	4.45	4.02	4.59
Restricted Cash	-	-	-	0.02	0.02	-
Total Current Assets	453.61	158.22	208.82	72.07	117.66	96.1
Property, Plant & Equipment	72.25	54.85	59.54	65.15	55.65	12.92
Goodwill	106.34	106.32	106.25	106.38	106.56	104.11
Other Intangible Assets	23.37	1.41	13.18	29.18	42.22	49.13
Long-Term Deferred Tax Assets	-	0.14	0.23	0.18	-	-
Other Long-Term Assets	22.59	2.14	2.3	2.25	2.66	2.56
Total Assets	681.54	323.07	390.31	275.21	324.76	264.81
Accounts Payable	10.93	9.24	7.91	10.6	9.22	5.15
Accrued Expenses	21.66	14.41	7.52	13.59	24.01	12.64
Short-Term Debt	-	-	-	6.84	-	-
Current Portion of Long-Term Debt	54.91	59.53	2.08	-	-	-
Current Portion of Leases	6.12	4.32	3.68	3.05	2.97	1.83
Current Income Taxes Payable	-	1.23	1.44	-	-	-
Current Unearned Revenue	16.97	15.22	14.44	15.48	16.39	11.8
Other Current Liabilities	10.03	5.38	6.37	-	1.66	1.39
Total Current Liabilities	120.62	109.33	43.44	49.57	54.25	32.82
Long-Term Debt	0.3	3.98	62.81	64.21	54.22	53.82
Long-Term Leases	28.14	30.37	34.08	37.55	38.18	4.32
Long-Term Unearned Revenue	40.8	14.28	18.18	24.08	29.03	8.17
Long-Term Deferred Tax Liabilities	0.84	0.84	1.06	4.33	8.7	11.49
Other Long-Term Liabilities	1.51	1.07	0.96	0.88	1.33	0.57
Total Liabilities	192.21	159.87	160.52	180.62	185.71	111.2
Common Stock	0.39	0.08	0.08	0.08	0.08	0.07
Additional Paid-In Capital	1,688	860.82	847.01	831.42	815.62	777.77
Retained Earnings	-1,152	-1,001	-926.1	-736	-676.76	-623.64
Treasury Stock	-46.47	-5.98	-0.56	-	-	-
Comprehensive Income & Other	-1.41	-2.22	-1.9	-0.91	0.11	-0.58
Total Common Equity	489.33	-148.05	-81.47	94.6	139.05	153.61
Shareholders' Equity	489.33	163.2	229.79	94.6	139.05	153.61
Total Liabilities & Equity	681.54	323.07	390.31	275.21	324.76	264.81
Total Debt	89.47	98.21	102.66	111.65	95.38	59.98
Net Cash (Debt)	276.86	16.69	63.13	-83.2	-26.86	-1.34
Net Cash Growth	850.42%	-73.57%	-	-	-	-
Net Cash Per Share	0.99	0.21	0.81	-1.10	-0.37	-0.02
Filing Date Shares Outstanding	372.26	290.12	79.06	77.2	74.55	70.45
Total Common Shares Outstanding	372.26	80.23	79.48	76.92	74.54	69.96
Working Capital	332.99	48.89	165.37	22.5	63.41	63.28
Book Value Per Share	1.31	-1.85	-1.02	1.23	1.87	2.20
Tangible Book Value	359.62	-255.78	-200.9	-40.97	-9.74	0.37
Tangible Book Value Per Share	0.97	-3.19	-2.53	-0.53	-0.13	0.01
Buildings	3.48	1.76	1.71	-	-	-
Machinery	67.63	41.8	39.12	38.09	24.34	25.15
Construction In Progress	6.22	2.33	1.61	4.55	9.98	0.08
Leasehold Improvements	17.4	13.79	12.23	12.1	7.2	7.79

Source: S&P Capital IQ. Standard template. Financial Sources.